RAPT Therapeutics
RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
Last updated on
About RAPT Therapeutics
Founded
2015Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$24MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
87NAICs Code
541711Location
City
South San FranciscoState
CaliforniaCountry
United StatesTech Stack (82)
